Salbutamol for analgesia in renal colic: A prospective, randomised, placebo-controlled Phase II trial (SARC)

Graham Johnson(Royal Derby Hospital), Suzanne Mason(University of Sheffield), Hari L. Ratan(Nottingham University Hospitals NHS Trust), Andrew Tabner(Portsmouth Hospitals NHS Trust), Rachelle Sherman(Royal Derby Hospital), Richard Jackson(University of Liverpool), Apostolos Fakis(Royal Derby Hospital), Liz Bedford(University Hospitals of Derby and Burton NHS Foundation Trust), Victoria Chester(Royal Derby Hospital)
Research Square
February 25, 2022
10.21203/rs.3.rs-1323945/v1
Cited by 0

Related Papers

Mitigating the Psychological Impact of COVID-19 on Healthcare Workers: A Digital Learning Package
|International Journal of Environmental Research and Public Health|2020|685
The clinical effectiveness of the STUMBL score for the management of ED patients with blunt chest trauma compared to clinical evaluation alone
|Internal and Emergency Medicine|2022|17
Increased Risk of Acute Pancreatitis with Codeine Use in Patients with a History of Cholecystectomy
|Digestive Diseases and Sciences|2019|15
Prospective observational study to examine health-related quality of life and develop models to predict long-term patient-reported outcomes 6 months after hospital discharge with blunt thoracic injuries
|BMJ Open|2021|10
Salbutamol for analgesia in renal colic: study protocol for a prospective, randomised, placebo-controlled phase II trial (SARC)
|Trials|2022|7